HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshifumi Kagamiishi Selected Research

Yoshifumi Kagamiishi Research Topics

Disease

3Infarction (Infarctions)
07/2004 - 06/2002
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2004 - 06/2002
1Parkinson Disease (Parkinson's Disease)
12/2018
1Stroke (Strokes)
06/2006
1Inflammation (Inflammations)
02/2006
1Brain Ischemia (Cerebral Ischemia)
07/2004
1Hypoxia (Hypoxemia)
01/2004
1Ischemia
01/2004
1Hypoglycemia (Reactive Hypoglycemia)
01/2004
1Anxiety Disorders (Anxiety Disorder)
11/2003
1Neurologic Manifestations (Neurological Manifestations)
06/2002

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
06/2006 - 02/2006
2EnzymesIBA
02/2006 - 06/2002
2ONO2506IBA
07/2004 - 06/2002
2S100 Calcium Binding Protein beta SubunitIBA
07/2004 - 06/2002
1ProdrugsIBA
12/2018
1Carbidopa (Lodosyn)FDA LinkGeneric
12/2018
1Levodopa (L Dopa)FDA LinkGeneric
12/2018
1Glutamic Acid (Glutamate)FDA Link
07/2004
1Messenger RNA (mRNA)IBA
07/2004
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
01/2004
1Corticotropin-Releasing HormoneIBA
01/2004
1astressinIBA
01/2004
1Serotonin (5 Hydroxytryptamine)IBA
11/2003
1Biotin (Vitamin H)FDA Link
06/2002
1Glial Fibrillary Acidic ProteinIBA
06/2002
1CytokinesIBA
06/2002
1triphosphoric acid (triphosphate)IBA
06/2002
1Monoclonal AntibodiesIBA
06/2002
1DeoxyuridineIBA
06/2002
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
06/2002

Therapy/Procedure

1Intravenous Administration
06/2002